Literature DB >> 9693420

Elimination of Staphylococcus intermedius in healthy dogs by topical treatment with fusidic acid.

L Saijonmaa-Koulumies1, E Parsons, D H Lloyd.   

Abstract

Cutaneous and mucosal carriage of Staphylococcus intermedius was investigated in six healthy beagles before and after application of fusidic acid to mucosal surfaces as 1 per cent viscous eye drops twice daily for seven days. Bacterial populations were determined repeatedly over four weeks using quantitative techniques. The overall cutaneous populations of S intermedius reduced significantly (P < 0.001) two days after treatment but returned to pretreatment levels after a further week. The mucosal frequency of S intermedius reduced significantly (P < 0.01) two days after treatment and remained reduced (P < 0.01) at the end of the study. The mucosal populations were also reduced (P < 0.01) two days after treatment and remained lower (P < 0.05) after a further week. No such changes occurred in the control group of six beagles. The study indicates the importance of mucosae as carriage sites for S intermedius in dogs. This form of therapy may be useful as an additional tool against canine recurrent pyoderma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693420     DOI: 10.1111/j.1748-5827.1998.tb03725.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  2 in total

1.  Suggested guidelines for using systemic antimicrobials in bacterial skin infections: part 2-- antimicrobial choice, treatment regimens and compliance.

Authors:  L Beco; E Guaguère; C Lorente Méndez; C Noli; T Nuttall; M Vroom
Journal:  Vet Rec       Date:  2013-02-09       Impact factor: 2.695

2.  Epidemiology of methicillin resistant Staphylococcus pseudintermedius in guide dogs in Finland.

Authors:  Thomas Grönthal; Matti Ollilainen; Marjut Eklund; Heli Piiparinen; Veera Gindonis; Jouni Junnila; Leena Saijonmaa-Koulumies; Riitta Liimatainen; Merja Rantala
Journal:  Acta Vet Scand       Date:  2015-07-17       Impact factor: 1.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.